FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1620795552> ?p ?o ?g. }

• W1620795552 endingPage "609" @default.
• W1620795552 startingPage "597" @default.
• W1620795552 abstract "Although neuroprotective strategies and pharmaceutical agents have been initiated in the treatment of numerous disorders of the central and peripheral nervous systems, including trauma, epilepsy, stroke, Huntington disease, amyotrophic lateral sclerosis,and AIDS dementia, none have yet been applied to the treatment of glaucoma. A prospective, placebo-controlled, multi-institutional trial of memantine is underway. One would not expect the treatment modalities that form the bases of nonpharmaceutical, traditional medical systems to be used to lower IOP. Glaucoma was unknown when these medicinal treatments were developed over the centuries. Their primary use is in improving the cardiovascular and immune systems and in what is now called neuro-protection. Rather than single compounds that target a specific receptor and have demarcated side effects in other systems, plant products are a blend of many compounds and, according to those most versed in them, they achieve a balanced therapy, helping in specific symptomatic complexes while reducing side effects through ameliorating effects in other areas. It is not insignificant that, now that the rain forests are rapidly dwindling, together with their inhabitants and the knowledge of medicinal plants (especially in South America), the pharmaceutical companies are spending large amounts of money in a sudden, almost frantic attempt to gather the knowledge about rainforest plants before all has been completely lost. Proof of effects clinically in a chronic disease such as glaucoma remains largely lacking, and controlled trials are unlikely to be initiated, except perhaps through the National Institutes of Health, because these compounds have been in the public domain for many years. Perhaps those as yet unknown or un-recorded are patentable and perhaps these include drugs known only to small surviving communities of hunter-gatherers, which explains the pharmaceutical interest in these areas. When more accurate and rapid means of assessment of progression of glaucomatous damage than perimetry and optic nerve head photography are eventually developed and trials can be reduced in time, number of subjects, or even the use of nonhuman subjects for the bulk of studies, studies could be done for verification of effect of various compounds and also comparative studies. At the present time, GBE is the best documented of all the complementary medicinal agents and seems to have the greatest potential value. Ginkgo biloba extract has numerous properties that theoretically should be beneficial in treating non-IOP-dependent mechanisms in glaucoma. Its multi-ple beneficial actions, including increased ocular blood flow, antioxidant activity, platelet activating factor inhibitory activity, nitric oxide inhibition, and neuroprotective activity, combine to suggest that GBE could prove to be of major therapeutic value in the treatment of glaucoma." @default.
• W1620795552 created "2016-06-24" @default.
• W1620795552 creator A5062127850 @default.
• W1620795552 date "2005-12-01" @default.
• W1620795552 modified "2023-09-23" @default.
• W1620795552 title "Complementary therapy for the treatment of glaucoma: a perspective." @default.
• W1620795552 cites W101276315 @default.
• W1620795552 cites W132797949 @default.
• W1620795552 cites W145646312 @default.
• W1620795552 cites W1500541392 @default.
• W1620795552 cites W1544178675 @default.
• W1620795552 cites W1552608885 @default.
• W1620795552 cites W1562618094 @default.
• W1620795552 cites W158377264 @default.
• W1620795552 cites W1601027696 @default.
• W1620795552 cites W1624269173 @default.
• W1620795552 cites W1709747402 @default.
• W1620795552 cites W1880421453 @default.
• W1620795552 cites W1904978905 @default.
• W1620795552 cites W1941964179 @default.
• W1620795552 cites W1965798202 @default.
• W1620795552 cites W1965925231 @default.
• W1620795552 cites W1966768984 @default.
• W1620795552 cites W1970385641 @default.
• W1620795552 cites W1971305021 @default.
• W1620795552 cites W1971363665 @default.
• W1620795552 cites W1974082153 @default.
• W1620795552 cites W1977698530 @default.
• W1620795552 cites W1979125328 @default.
• W1620795552 cites W1980004643 @default.
• W1620795552 cites W1981297144 @default.
• W1620795552 cites W1981728153 @default.
• W1620795552 cites W1983457180 @default.
• W1620795552 cites W1983584247 @default.
• W1620795552 cites W1989409193 @default.
• W1620795552 cites W199142598 @default.
• W1620795552 cites W1991502499 @default.
• W1620795552 cites W1993099285 @default.
• W1620795552 cites W1993151059 @default.
• W1620795552 cites W1993872576 @default.
• W1620795552 cites W1996011091 @default.
• W1620795552 cites W1996598619 @default.
• W1620795552 cites W1998294567 @default.
• W1620795552 cites W1999672768 @default.
• W1620795552 cites W2000668452 @default.
• W1620795552 cites W2003384166 @default.
• W1620795552 cites W2004684435 @default.
• W1620795552 cites W2009670021 @default.
• W1620795552 cites W2012296679 @default.
• W1620795552 cites W2012761652 @default.
• W1620795552 cites W2013995428 @default.
• W1620795552 cites W2017083562 @default.
• W1620795552 cites W2017252693 @default.
• W1620795552 cites W2018072158 @default.
• W1620795552 cites W2019641244 @default.
• W1620795552 cites W2019893837 @default.
• W1620795552 cites W2020487819 @default.
• W1620795552 cites W2021729620 @default.
• W1620795552 cites W2021877145 @default.
• W1620795552 cites W2022456824 @default.
• W1620795552 cites W2023732540 @default.
• W1620795552 cites W2031941651 @default.
• W1620795552 cites W2034601808 @default.
• W1620795552 cites W2035027020 @default.
• W1620795552 cites W2036163353 @default.
• W1620795552 cites W2036871785 @default.
• W1620795552 cites W2038298943 @default.
• W1620795552 cites W2038570828 @default.
• W1620795552 cites W2039277124 @default.
• W1620795552 cites W2039815400 @default.
• W1620795552 cites W2040307572 @default.
• W1620795552 cites W2043243971 @default.
• W1620795552 cites W2044115540 @default.
• W1620795552 cites W2044520613 @default.
• W1620795552 cites W2045037055 @default.
• W1620795552 cites W2046542347 @default.
• W1620795552 cites W2047587902 @default.
• W1620795552 cites W2050739489 @default.
• W1620795552 cites W2051882173 @default.
• W1620795552 cites W2051924759 @default.
• W1620795552 cites W2052174985 @default.
• W1620795552 cites W2052458656 @default.
• W1620795552 cites W2053031729 @default.
• W1620795552 cites W2055140428 @default.
• W1620795552 cites W2060206336 @default.
• W1620795552 cites W2060403639 @default.
• W1620795552 cites W2061853325 @default.
• W1620795552 cites W2063051445 @default.
• W1620795552 cites W2063174138 @default.
• W1620795552 cites W2064646467 @default.
• W1620795552 cites W2066903456 @default.
• W1620795552 cites W2070009772 @default.
• W1620795552 cites W2073399650 @default.
• W1620795552 cites W2075537831 @default.
• W1620795552 cites W2076656151 @default.
• W1620795552 cites W2077516224 @default.
• W1620795552 cites W2079383900 @default.
• W1620795552 cites W2079959397 @default.

• next